Instrumento Inactivo

Acciones Anacor Pharmaceuticals Inc

Acciones

Precio de cierre Nasdaq Otros sitios de cotización
- ^USD	-

Anacor Pharmaceuticals : received rival bid before Pfizer deal - filing	26/05/16
Ryan & Maniskas, LLP : Announces Investigation of Anacor Pharmaceuticals, Inc.	18/05/16
Brower Piven Commences an Investigation into the Proposed Sale of Anacor Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information	17/05/16
Brower Piven Commences an Investigation into the Proposed Sale of Anacor Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm for Additional Information	16/05/16
Anacor Pharmaceuticals : Pfizer to buy Anacor in $5.2 billion deal for access to eczema gel	16/05/16

Directores	Puesto	Edad	Desde
Douglas Giordano CEO	Chief Executive Officer	61	24/06/16
Jacob John Plattner CTO	Chief Tech/Sci/R&D Officer	77	01/02/04
Margaret M. Madden BRD	Director/Board Member	-	24/06/16

Administradores	Puesto	Edad	Desde
Douglas Giordano CEO	Chief Executive Officer	61	24/06/16
Bryan Supran BRD	Director/Board Member	-	24/06/16
Margaret M. Madden BRD	Director/Board Member	-	24/06/16

Sector

	Varia. 1 de ene.	Capi.
IQVIA HOLDINGS INC.	+1,51 %	42,75 mil M
LONZA GROUP AG	+49,22 %	41,61 mil M
MODERNA, INC.	+8,57 %	41,34 mil M
CELLTRION, INC.	-12,36 %	26,59 mil M
ICON PUBLIC LIMITED COMPANY	+8,92 %	25,49 mil M
ALNYLAM PHARMACEUTICALS, INC.	-25,13 %	18,12 mil M
MEDPACE HOLDINGS, INC.	+29,17 %	12,24 mil M
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-3,12 %	11,76 mil M
UNITED THERAPEUTICS CORPORATION	+6,35 %	11 mil M